Scholars Central

Conference abstractPublished 17 Sep 2018

Employing chemical glycobiology for immunotherapeutic approaches directed at cancer

Authors: Peter R Andreana

University of Toledo, USA

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The overarching goal for our research is to develop a cancer immuno therapeutics that target tumor-associated-carbohydrateantigens (TACAs) Tn and STn found on malignant cells. In the process of carcinogenesis, certain glycosyltransferases are over-expressed, which lead to different glycosylation patterns than those of normal cells. For example, the Thomsennouveau (Tn) and sialyl-Tn (STn) antigens are expressed abundantly on human breast, ovarian and colon cancers. These abnormal glycosylations on tumor cell surfaces provide significant opportunities for researchers to develop carbohydratebased anticancer therapeutics. The strategy used for most carbohydrate-based cancer vaccines entails immunogenic proteins as carriers to cross over into the cellular arm of the immune system because of the inherent T-cell independent nature of TACSs. There are both advantages and disadvantages for this strategy. We have been working with the unique zwitter ionic capsular polysaccharide PS A1 to find alternative pathways avoiding protein carriers and at same time retain both a cellular and humoral immune response. PS A1 is found on Bacteroides fragilis' cell wall, consisting of a tetra saccharide-core repeating unit carrying an electrostatic charge character on adjacent mono saccharides able to induce a specific and selective immune response similar to that noted for exogenous proteins. This seminar will describe the synthesis of TACA-PS A1 conjugates and their application in glycol-immunology.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Glycobiology
  • SubjectChemistry
  • SubjectImmunology & Microbiology
  • SubjectOncology & Cancer
  • BylineArticles whose byline prints “Peter R Andreana”